Form 8-K - Current report:
SEC Accession No. 0001564590-20-013641
Filing Date
2020-03-27
Accepted
2020-03-27 16:53:20
Documents
14
Period of Report
2020-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-8k_20200323.htm   iXBRL 8-K 66378
2 EX-10.1 idxx-ex101_6.htm EX-10.1 92514
3 GRAPHIC gromsr5knrt2000001.jpg GRAPHIC 2144
  Complete submission text file 0001564590-20-013641.txt   304905

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA idxx-20200323.xsd EX-101.SCH 5764
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20200323_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20200323_pre.xml EX-101.PRE 11164
11 EXTRACTED XBRL INSTANCE DOCUMENT idxx-8k_20200323_htm.xml XML 3420
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 20752563
SIC: 2835 In Vitro & In Vivo Diagnostic Substances